Semus Wealth Partners LLC Has $315,000 Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Semus Wealth Partners LLC trimmed its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 23.1% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 603 shares of the medical equipment provider’s stock after selling 181 shares during the period. Semus Wealth Partners LLC’s holdings in Intuitive Surgical were worth $315,000 as of its most recent SEC filing.

Other institutional investors have also recently bought and sold shares of the company. Bennett Selby Investments LP increased its stake in shares of Intuitive Surgical by 3.9% in the fourth quarter. Bennett Selby Investments LP now owns 449 shares of the medical equipment provider’s stock valued at $234,000 after buying an additional 17 shares in the last quarter. LVW Advisors LLC grew its holdings in Intuitive Surgical by 1.3% during the 4th quarter. LVW Advisors LLC now owns 1,448 shares of the medical equipment provider’s stock worth $756,000 after acquiring an additional 19 shares during the last quarter. Wesbanco Bank Inc. increased its position in Intuitive Surgical by 1.6% in the 4th quarter. Wesbanco Bank Inc. now owns 1,216 shares of the medical equipment provider’s stock valued at $635,000 after acquiring an additional 19 shares in the last quarter. FSM Wealth Advisors LLC raised its stake in shares of Intuitive Surgical by 3.7% in the fourth quarter. FSM Wealth Advisors LLC now owns 526 shares of the medical equipment provider’s stock worth $275,000 after acquiring an additional 19 shares during the last quarter. Finally, Journey Strategic Wealth LLC lifted its position in shares of Intuitive Surgical by 1.9% during the fourth quarter. Journey Strategic Wealth LLC now owns 1,039 shares of the medical equipment provider’s stock worth $542,000 after purchasing an additional 19 shares in the last quarter. Institutional investors own 83.64% of the company’s stock.

Insider Buying and Selling

In related news, EVP Myriam Curet sold 408 shares of the business’s stock in a transaction on Tuesday, February 11th. The shares were sold at an average price of $589.75, for a total value of $240,618.00. Following the sale, the executive vice president now directly owns 353 shares of the company’s stock, valued at approximately $208,181.75. The trade was a 53.61 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, CFO Jamie Samath sold 269 shares of the stock in a transaction dated Monday, February 10th. The stock was sold at an average price of $590.00, for a total value of $158,710.00. Following the transaction, the chief financial officer now owns 3,282 shares of the company’s stock, valued at approximately $1,936,380. This trade represents a 7.58 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders sold 6,348 shares of company stock valued at $3,587,582. 0.80% of the stock is owned by corporate insiders.

Intuitive Surgical Price Performance

Shares of Intuitive Surgical stock opened at $601.17 on Wednesday. Intuitive Surgical, Inc. has a 1 year low of $364.17 and a 1 year high of $616.00. The company has a market capitalization of $214.12 billion, a P/E ratio of 93.79, a price-to-earnings-growth ratio of 5.74 and a beta of 1.39. The business has a 50-day moving average of $561.88 and a two-hundred day moving average of $522.27.

Analysts Set New Price Targets

A number of brokerages recently weighed in on ISRG. Royal Bank of Canada raised their price target on shares of Intuitive Surgical from $611.00 to $641.00 in a report on Monday, January 27th. Barclays boosted their target price on Intuitive Surgical from $610.00 to $674.00 in a research report on Monday, January 27th. Raymond James raised their price target on Intuitive Surgical from $560.00 to $688.00 and gave the company an “outperform” rating in a report on Friday, January 24th. Citigroup boosted their price objective on Intuitive Surgical from $640.00 to $711.00 and gave the stock a “buy” rating in a report on Friday, January 24th. Finally, UBS Group raised their target price on shares of Intuitive Surgical from $500.00 to $560.00 and gave the company a “neutral” rating in a research note on Monday, January 27th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have given a buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $613.10.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.